Renata (DHA:RENATA) Total Operating Expense: BDT14,531 Mil (TTM As of Mar. 2026)


DHA:RENATA Renata PLC DHA:RENATA
85 GF Score
Price BDT463.90
GF Value BDT813.06
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Renata Total Operating Expense?

Renata DHA:RENATA +0.74% 85 Total Operating Expense is BDT14,531 Mil as of Mar. 2026. GuruFocus rates DHA:RENATA with a GF Score™ of 85/100 and a GF Value™ of BDT813.06 (Significantly Undervalued). The stock has 7 warning signs investors should review.

Renata's Total Operating Expense for the three months ended in Mar. 2026 was BDT3,827 Mil. Renata's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was BDT14,531 Mil.

Renata Total Operating Expense Related Terms

Renata Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Renata's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Renata Total Operating Expense Chart

Renata Annual Data
Trend Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7,632.33 8,505.22 10,670.10 11,577.54 13,483.45

Renata Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,380.32 3,475.93 3,685.04 3,543.36 3,826.81
DHA:RENATA
85GF Score
Renata PLC DHA:RENATA
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Renata Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT14,531 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of BDT14,531 Mil mean?
Renata (DHA:RENATA) has a Total Operating Expense of BDT14,531 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Renata and its competitors.
Is Renata's Total Operating Expense too high?
Renata's current Total Operating Expense is BDT14,531 Mil. Overall, Renata has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Renata's Total Operating Expense compare to ZTS and UTHR?
Renata's Total Operating Expense of BDT14,531 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Drug Manufacturers company?
A good Total Operating Expense depends on the Drug Manufacturers industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Renata and its competitors. Renata's current Total Operating Expense is BDT14,531 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Renata stock overvalued right now?
Based on GuruFocus' analysis, Renata (DHA:RENATA) is currently considered Significantly Undervalued. The stock's GF Value™ is BDT813.06, compared to a current price of BDT463.90 — trading 42.9% below its estimated fair value. The current Total Operating Expense is BDT14,531 Mil. Renata's overall GF Score™ is 85/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Renata (DHA:RENATA), the current Total Operating Expense is BDT14,531 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Renata (DHA:RENATA) Overvalued in 2026?

Based on GuruFocus' analysis, Renata stock appears to be undervalued. The current stock price of BDT463.90 is trading 42.9% below its estimated GF Value™ of BDT813.06. GuruFocus considers Renata to be Significantly Undervalued.

Key valuation signals for DHA:RENATA:

  • Total Operating Expense: BDT14,531 Mil
  • GF Value™: BDT813.06 vs. price of BDT463.90 (42.9% below fair value)
  • GF Score™: 85/100 with 7 warning signs

No single metric tells the full story. See the DHA:RENATA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Renata Business Description

Address Plot Number 1, Milk Vita Road, Section-7, GPO Box No. 303, Mirpur, Dhaka, BGD, 1216
Renata PLC is a Bangladesh based pharmaceutical company. It is engaged in the manufacturing, marketing, and distribution of Human Pharmaceuticals, Animal Health Medicines, Nutritionals, and Vaccines. It manufactures various pharmaceutical products including Beconex Zi Syrup, Cabolin Tablet, Flontin Tablet, Ivana Tablet, and others. Some of the animal health products offered by the company are Doxivet Powder, Fevenil Injection, Diadin Bolus, Renamet Tablet, and others. The company operates in Bangladesh and sells its products locally and internationally.
85GF Score

Get the complete analysis for DHA:RENATA

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT463.90
Price
BDT813.06
GF Value